SRX316677 T cell activation SRP026389 Purified CCR6 T cells were stimulated with anti-CD3 and anti-CD28. The sequencing was done using Illumina HiSeq 2000 platform. SRS453986 JNJ1 CD4 T cell 0hr RNA-Seq TRANSCRIPTOMIC unspecified 180 0 Application Read Forward 1 1 Application Read Reverse 91 Illumina HiSeq 2000 SRX317155 T cell activation at 0hr SRP026389 PRJNA209867 Purified CCR6 T cells were stimulated with anti-CD3 and anti-CD28. The sequencing was done using Illumina HiSeq 2000 platform. SRS453987 SAMN02215313 RNA-Seq TRANSCRIPTOMIC unspecified 180 0 Application Read Forward 1 1 Application Read Reverse 91 Illumina HiSeq 2000 SRX317156 T cell activation at 2hr-a SRP026389 PRJNA209867 Purified CCR6 T cells were stimulated with anti-CD3 and anti-CD28. The sequencing was done using Illumina HiSeq 2000 platform. SRS454391 SAMN02215314 RNA-Seq TRANSCRIPTOMIC unspecified 180 0 Application Read Forward 1 1 Application Read Reverse 91 Illumina HiSeq 2000 SRX317157 T cell activation at 2hr-b SRP026389 PRJNA209867 Purified CCR6 T cells were stimulated with anti-CD3 and anti-CD28. The sequencing was done using Illumina HiSeq 2000 platform. SRS454392 SAMN02215315 RNA-Seq TRANSCRIPTOMIC unspecified 180 0 Application Read Forward 1 1 Application Read Reverse 91 Illumina HiSeq 2000 SRX317158 T cell activation at 4hr-a SRP026389 PRJNA209867 Purified CCR6 T cells were stimulated with anti-CD3 and anti-CD28. The sequencing was done using Illumina HiSeq 2000 platform. SRS454394 SAMN02215316 RNA-Seq TRANSCRIPTOMIC unspecified 180 0 Application Read Forward 1 1 Application Read Reverse 91 Illumina HiSeq 2000 SRX317159 T cell activation at 4hr-b SRP026389 PRJNA209867 Purified CCR6 T cells were stimulated with anti-CD3 and anti-CD28. The sequencing was done using Illumina HiSeq 2000 platform. SRS454393 SAMN02215317 RNA-Seq TRANSCRIPTOMIC unspecified 180 0 Application Read Forward 1 1 Application Read Reverse 91 Illumina HiSeq 2000 SRX317160 T cell activation at 6hr-a SRP026389 PRJNA209867 Purified CCR6 T cells were stimulated with anti-CD3 and anti-CD28. The sequencing was done using Illumina HiSeq 2000 platform. SRS454395 SAMN02215318 RNA-Seq TRANSCRIPTOMIC unspecified 180 0 Application Read Forward 1 1 Application Read Reverse 91 Illumina HiSeq 2000 SRX317161 T cell activation at 6hr-b SRP026389 PRJNA209867 Purified CCR6 T cells were stimulated with anti-CD3 and anti-CD28. The sequencing was done using Illumina HiSeq 2000 platform. SRS454396 SAMN02215319 RNA-Seq TRANSCRIPTOMIC unspecified 180 0 Application Read Forward 1 1 Application Read Reverse 91 Illumina HiSeq 2000 SRX317162 T cell activation at 24hr-a SRP026389 PRJNA209867 Purified CCR6 T cells were stimulated with anti-CD3 and anti-CD28. The sequencing was done using Illumina HiSeq 2000 platform. SRS454397 SAMN02215320 RNA-Seq TRANSCRIPTOMIC unspecified 180 0 Application Read Forward 1 1 Application Read Reverse 91 Illumina HiSeq 2000 SRX317163 T cell activation at 24hr-b SRP026389 PRJNA209867 Purified CCR6 T cells were stimulated with anti-CD3 and anti-CD28. The sequencing was done using Illumina HiSeq 2000 platform. SRS454398 SAMN02215321 RNA-Seq TRANSCRIPTOMIC unspecified 180 0 Application Read Forward 1 1 Application Read Reverse 91 Illumina HiSeq 2000 SRX317164 T cell activation at 72hr-a SRP026389 PRJNA209867 Purified CCR6 T cells were stimulated with anti-CD3 and anti-CD28. The sequencing was done using Illumina HiSeq 2000 platform. SRS454399 SAMN02215322 RNA-Seq TRANSCRIPTOMIC unspecified 180 0 Application Read Forward 1 1 Application Read Reverse 91 Illumina HiSeq 2000 SRX317165 T cell activation at 72hr-b SRP026389 PRJNA209867 Purified CCR6 T cells were stimulated with anti-CD3 and anti-CD28. The sequencing was done using Illumina HiSeq 2000 platform. SRS454400 SAMN02215323 RNA-Seq TRANSCRIPTOMIC unspecified 180 0 Application Read Forward 1 1 Application Read Reverse 91 Illumina HiSeq 2000